Palisade bio presents development overview of pali-2108 at the ibd innovate: product development for crohn's & colitis™

– pali-2108 in development for the treatment of moderate-to-severe ulcerative colitis (uc) advancing towards phase 1 clinical study before year end

PALI Ratings Summary

PALI Quant Ranking